Dosing devices for liquid medicines are generally not interchangeable. To avoid dosing errors, the FAMHP recalls the importance of using the dosing device supplied with the medicine.
Flash VIG-news: avoid errors in dosing oral liquid forms by using the dosing device supplied with the medicine
Coronavirus: hydroxychloroquine, chloroquine and Kaletra (lopinavir & ritonavir) are subject to controlled distribution in Belgium to enhance monitoring of treatments
Hydroxychloroquine, chloroquine and Kaletra (lopinavir & ritonavir) are used to treat patients with COVID-19. The FAMHP has quarantined available stocks of these medicines to control their distribution, improve monitoring of their use and limit the risks to patients. Do not take any of these medicines without medical supervision.
If you have symptoms that might indicate an infection linked to coronavirus, paracetamol remains the first choice for cases of fever and pain.
Some painkillers (paracetamol, over-the-counter non-steroid anti-inflammatory drugs (NSAIDs) and acetylsalicylic acid) are often used without medical advice for pain and high temperature. To improve proper use of these drugs, the FAMHP is drawing attention to a number of precautionary measures. The FAMHP also reminds holders of marketing authorisations that directives have recently been updated as regards medication containing paracetamol.
The FAMHP launches PharmaStatus, the new online application that collects information about the availability of medicines in Belgium and makes it public. Current information will help patients, doctors, pharmacists and the pharmaceutical industry to limit the impact of unavailable medicines.
Is the electronic patient information leaflet just as effective as the paper version? e-PIL pilot project evaluation
Last year, the e-PIL pilot project on the electronic patient information leaflet started. Hospital pharmacists will soon receive a link to an online survey to evaluate the project, one year after its start.
Limited availability of Clamoxyl I.V.-I.M. for injection or infusion: recommendations for hospital pharmacists and specialists
GSK can only produce 40% of the quantity of Clamoxyl I.V.-I.M. required each year because of a shortage of raw materials. The Federal Agency for Medicines and Health Products (FAMHP) and the National Institute for Health and Disability Insurance (RIZIV) are issuing recommendations for hospital pharmacists and hospital-based specialists.
The famhp is launching on 29th April 2013 an awareness campaign, "MEDICINES AND CHILDREN: ATTENTION, A MEDICINE IS NOT A SWEET! " and it offers some tips to help the proper use of medicines in children. On this occasion three brochures to assist the public in determining when and how to give a medicine to a child are being distributed through doctors' and pediatricians’ surgeries, pharmacies and also during ONE and Kind en Gezin consultations. They are also available and downloadable from the website www.médicamentsetenfants.be.